---
action_items:
- id: 40d0904b4557
  severity: science
  text: Report standard deviations or 95% confidence intervals for all success rate
    metrics in Tables 1, 2, and Figure 1a to quantify evaluation variance.
- id: 6f84dacb787a
  severity: science
  text: Perform statistical significance tests (e.g., bootstrap or t-tests) for comparisons
    against baselines and ablation components to validate performance claims.
- id: fa0cc870e9c0
  severity: science
  text: Address the small sample size (N=10) in Section 5.5 by increasing trials or
    qualifying the '4x improvement' claim to reflect high uncertainty.
artifact_hash: 6c4849a863c2eceb9d37c40ec304abc1094d51d7aac9811d5d8ec7767658ab60
artifact_path: projects/PROJ-730-ace-ego-0-unifying-egocentric-human-and/paper/metadata.json
backend: dartmouth
feedback: ''
github_authenticated: false
model_name: qwen.qwen3.5-122b
prompt_version: 1.1.0
reviewed_at: '2026-06-27T17:28:40.633812Z'
reviewer_kind: llm
reviewer_name: paper_reviewer_statistical_analysis
score: 0.0
verdict: minor_revision
---

The statistical reporting in this manuscript requires significant improvement to support the claims of state-of-the-art performance. While the experimental setup is described, the analysis of results lacks essential statistical rigor.

First, all success rate metrics in Tables 1 and 2 (Sections 5.2.1 and 5.2.2) and Figure 1a (Section 5.3) are reported as point estimates without measures of variance (e.g., standard deviation or 95% confidence intervals). Success rates are binomial proportions; without error bars, it is impossible to assess the reliability of the reported averages or the significance of the differences between \Ours and baselines. For instance, the 0.64% improvement over JoyAI-RA on RoboTwin Easy (Table 2) may not be statistically significant given the variance inherent in rollout-based evaluation.

Second, no statistical significance tests (e.g., bootstrap, t-tests, or McNemar's test) are performed to validate the claims of outperformance. The ablation study in Figure 1b reports performance drops (e.g., -3.6% for reliability-aware loss) without indicating if these differences exceed the noise floor of the evaluation protocol.

Third, the fine-tuning experiment in Section 5.5 relies on only 10 trials per condition ("1/10 trials" to "4/10 trials"). Claiming a "4x improvement" based on such a small sample size is statistically fragile. The authors should either increase the number of trials or qualify the claim to reflect the high uncertainty associated with N=10.

Finally, with multiple baselines and tasks compared, the risk of Type I errors increases. While the paper focuses on average performance, acknowledging multiple-comparison issues or applying corrections where specific task-level claims are made would strengthen the analysis.

To ensure reproducibility and scientific validity, the authors must report variance metrics and conduct significance testing for all primary comparisons.
